UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CMV: Prevention, Diagnosis and Therapy

American journal of transplantation, 2013-02, Vol.13 (s3), p.24-40

Kotton, C. N.

2013

Volltextzugriff (PDF)

Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial

Clinical infectious diseases, 2020-12, Vol.71 (9), p.2375-2385

2020

Volltextzugriff (PDF)

Cytomegalovirus in Solid Organ Transplant Recipients

American journal of transplantation, 2009-12, Vol.9, p.S78-S86

2009

Volltextzugriff (PDF)

Cytomegalovirus reactivation in ICU patients

Intensive care medicine, 2016-01, Vol.42 (1), p.28-37

2016

Volltextzugriff (PDF)

New data on efficacy of valacyclovir in secondary prevention of maternal–fetal transmission of cytomegalovirus

Ultrasound in obstetrics & gynecology, 2023-01, Vol.61 (1), p.59-66

2023

Volltextzugriff (PDF)

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

Blood, 2013-08, Vol.122 (7), p.1316-1324

2013

Volltextzugriff (PDF)

Infection in Solid-Organ Transplant Recipients

The New England journal of medicine, 2007-12, Vol.357 (25), p.2601-2614

Fishman, Jay A

2007

Volltextzugriff (PDF)

New Developments in the Management of Cytomegalovirus Infection After Transplantation

Drugs (New York, N.Y.), 2018-07, Vol.78 (11), p.1085-1103

2018

Volltextzugriff (PDF)

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

Transplantation, 2010-04, Vol.89 (7), p.779-795

2010

Volltextzugriff (PDF)

Cytomegalovirus Vaccines: Current Status and Future Prospects

Drugs (New York, N.Y.), 2016-11, Vol.76 (17), p.1625-1645

2016

Volltextzugriff (PDF)

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation

American journal of transplantation, 2020-06, Vol.20 (6), p.1703-1711

2020

Volltextzugriff (PDF)

Vaccine Prevention of Maternal Cytomegalovirus Infection

The New England journal of medicine, 2009-03, Vol.360 (12), p.1191-1199

2009

Volltextzugriff (PDF)

HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission

Proceedings of the National Academy of Sciences - PNAS, 2019-02, Vol.116 (9), p.3728-3733

2019

Volltextzugriff (PDF)

Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection

Clinical and vaccine immunology, 2017-12, Vol.24 (12)

2017

Volltextzugriff (PDF)

Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients

Antimicrobial agents and chemotherapy, 2017-02, Vol.61 (2)

2017

Volltextzugriff (PDF)

Efficacy, Safety, and Cost-effectiveness Analysis of Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Transplantation, 2024-04, Vol.108 (4), p.1021

2024

Volltextzugriff (PDF)

Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial

Annals of internal medicine, 2020-03, Vol.172 (5), p.306

2020

Volltextzugriff (PDF)

Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex

PLoS pathogens, 2014-11, Vol.10 (11), p.e1004524-e1004524

2014

Volltextzugriff (PDF)

Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease

The Journal of infectious diseases, 2020-03, Vol.221 (Supplement_1), p.S45-S59

2020

Volltextzugriff (PDF)

Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients

The Journal of infectious diseases, 2020-03, Vol.221 (7), p.1117-1126

2020

Volltextzugriff (PDF)

QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients

Transplantation, 2024-04, Vol.108 (4), p.985

2024

Volltextzugriff (PDF)

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

American journal of transplantation, 2010-05, Vol.10 (5), p.1228-1237

2010

Volltextzugriff (PDF)

Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis

American journal of transplantation, 2019-02, Vol.19 (2), p.573-584

2019

Volltextzugriff (PDF)

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

The New England journal of medicine, 2013-09, Vol.369 (13), p.1227-1236

2013

Volltextzugriff (PDF)

26 – 50 von 4.032

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieTransplantation Proceedings

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.491)
Mit Volltextzugriff
(2.751)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(3.730)
Science & Technology
(3.074)
Life Sciences & Biomedicine
(3.010)
Cytomegalovirus Infections - Prevention & Control
(2.773)
Female
(1.959)
Cytomegalovirus
(1.953)
Male
(1.437)
Adult
(1.365)
Biological And Medical Sciences
(1.149)
Transplantation
(1.094)
Immunology
(1.041)
Medical Sciences
(1.034)
Middle Aged
(1.027)
Antiviral Agents - Therapeutic Use
(989)
Infectious Diseases
(853)
Cytomegalovirus - Immunology
(709)
Infections
(704)
Risk Factors
(669)
Ganciclovir - Therapeutic Use
(657)
Adolescent
(622)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(3.993)
Journals@Ovid Full Text
(2.067)
EZB Electronic Journals Library
(1.738)
Ingenta
(1.387)
Publisher or Other Site
(885)
IngentaConnect Journals
(734)
Wiley-Blackwell Journals
(702)
Elsevier ScienceDirect Journals Complete
(656)
Wiley Online Library
(633)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(451)
Oxford Journals
(293)
Oxford Journals 2020 Medicine
(280)
SpringerLink
(273)
JSTOR
(271)
Nexis Uni
(195)
Nature International Weekly Journal of Science
(175)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(149)
Taylor & Francis Journals Auto-Holdings Collection
(123)
Taylor & Francis
(118)
Taylor & Francis Online
(89)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CMV: Prevention, Diagnosis and Therapy

Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial

Cytomegalovirus in Solid Organ Transplant Recipients

Cytomegalovirus reactivation in ICU patients

New data on efficacy of valacyclovir in secondary prevention of maternal–fetal transmission of cytomegalovirus

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

Infection in Solid-Organ Transplant Recipients

New Developments in the Management of Cytomegalovirus Infection After Transplantation

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

Cytomegalovirus Vaccines: Current Status and Future Prospects

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation

Vaccine Prevention of Maternal Cytomegalovirus Infection

HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission

Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection

Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients

Efficacy, Safety, and Cost-effectiveness Analysis of Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial

Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex

Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease

Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients

QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

Prevalence, Outcome, and Prevention of Congenital Cytomegalovirus Infection in Neonates Born to Women With Preconception Immunity (CHILd Study)

Aktive Filter

Suchergebnisse filtern